Harris M N, Crowther A, Jupp R A, Aps C
Department of Anaesthetics, St Thomas' Hospital, London.
Br J Anaesth. 1988 Jun;60(7):779-83. doi: 10.1093/bja/60.7.779.
Twenty patients, who underwent coronary revascularization without cardioplegic arrest, were given (during cardiopulmonary bypass) either magnesium chloride 16 mmol in 10 ml of water (magnesium group) or 10 ml of water alone (control group). Plasma and urinary magnesium concentrations were measured for 24 h after operation. ECG was recorded continuously during this period. QT intervals corrected for heart rate (QTcorr) were calculated from periodic full lead ECG. The mean plasma magnesium concentrations in the control group were less than normal throughout the study, while hypomagnesaemia did not occur in the magnesium group. Urinary magnesium excretion was higher in the magnesium group, with 58% of the administered magnesium excreted in the first 24 h. The observed incidence of frequent or ventricular arrhythmias was 22% in the magnesium group compared with 63% in the control group. No significant differences in QTcorr intervals were observed between the groups.
20例未进行心脏停搏的冠状动脉血运重建患者,在体外循环期间,一组给予10ml水中含16mmol氯化镁(镁组),另一组仅给予10ml水(对照组)。术后24小时测量血浆和尿镁浓度。在此期间持续记录心电图。根据定期全导联心电图计算心率校正QT间期(QTcorr)。在整个研究过程中,对照组的平均血浆镁浓度低于正常水平,而镁组未发生低镁血症。镁组尿镁排泄较高,给药镁的58%在最初24小时内排出。镁组频发或室性心律失常的观察发生率为22%,而对照组为63%。两组之间QTcorr间期未观察到显著差异。